AstraZeneca Named In Stock-Drop Suit Over COVID-19 Vaccine Misrepresentations

(January 28, 2021, 1:13 PM EST) -- NEW YORK — An investor sued biopharmaceutical company AstraZeneca PLC and certain of its senior executives in New York federal court on Jan. 26, alleging that the defendants misrepresented the success of clinical trials for the company’s COVID-19 vaccination candidate in violation of federal securities laws....